2517573-53-2
Chemical Structure
(Rac)-Bedaquiline-d6
- CAS No.: 2517573-53-2
- Formula:C32H25D6BrN2O2
- Molecular Weight:561.54
IUPAC Name: 4-(bis(methyl-d3)amino)-1-(6-bromo-2-methoxyquinolin-3-yl)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol
InChIKey: QUIJNHUBAXPXFS-WFGJKAKNSA-N
SMILES: BrC1=CC=C(N=C(OC)C(C(C(C2=CC=CC3=C2C=CC=C3)(O)CCN(C([2H])([2H])[2H])C([2H])([2H])[2H])C4=CC=CC=C4)=C5)C5=C1
Biological Activity: (Rac)-Bedaquiline-d6 is the deuterium labeled Bedaquiline (HY-14881)[1]. Bedaquiline (TMC207) is a diarylquinoline agent and inhibits Mycobacterium tuberculosis (Mtb) F1FO-ATP synthase through targeting of both the c- and the ε-subunit[2]. Bedaquiline has uncoupler activity. Bedaquiline is used for the multi-agent resistant tuberculosis[3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(Rac)-Bedaquiline-d6 | 99.0% | (Rac)-Bedaquiline-d6 is the deuterium labeled Bedaquiline (HY-14881). Bedaquiline (TMC207) is a diarylquinoline agent and inhibits Mycobacterium tuberculosis (Mtb) F1FO-ATP synthase through targeting of both the c- and the ε-subunit. Bedaquiline has uncoupler activity. Bedaquiline is used for the multi-agent resistant tuberculosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bedaquiline (Standard) | 99.96% | Bedaquiline (Standard) is the analytical standard of Bedaquiline. This product is intended for research and analytical applications. Bedaquiline (TMC207) is a diarylquinoline agent and inhibits Mycobacterium tuberculosis (Mtb) F1FO-ATP synthase through targeting of both the c- and the ε-subunit. Bedaquiline has uncoupler activity. Bedaquiline is used for the multi-agent resistant tuberculosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bedaquiline impurity 2-d6 | Bedaquiline impurity 2-d6 is deuterium labeled Bedaquiline. Bedaquiline (TMC207) is a diarylquinoline agent and inhibits Mycobacterium tuberculosis (Mtb) F1FO-ATP synthase through targeting of both the c- and the ε-subunit. Bedaquiline has uncoupler activity. Bedaquiline is used for the multi-agent resistant tuberculosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bedaquiline | 99.98% | Bedaquiline (TMC207) is a diarylquinoline agent and inhibits Mycobacterium tuberculosis (Mtb) F1FO-ATP synthase through targeting of both the c- and the ε-subunit. Bedaquiline has uncoupler activity. Bedaquiline is used for the multi-agent resistant tuberculosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
